Daniel Barber is the Chief Executive Officer at Aquestive Therapeutics Inc., a pharmaceutical company focused on developing and commercializing innovative drug products. With a robust background in the pharmaceutical industry, Barber brings extensive experience in leadership and strategic planning to his role at Aquestive. Prior to joining Aquestive, he held several high-level positions at various pharmaceutical companies, where he honed his skills in business development and operations management. At Aquestive Therapeutics, Barber is responsible for overseeing the company's overall strategy and operations. Under his leadership, the company has made significant strides in advancing its product pipeline and expanding its market presence. One of his key achievements at Aquestive has been the successful commercialization of several novel drug products, which have improved patient outcomes and strengthened the company's position in the industry. Barber's strategic vision and commitment to innovation have been instrumental in driving Aquestive's growth and success. In addition to his professional accomplishments, Barber is known for his dedication to fostering a collaborative and inclusive work environment. He actively engages with his team to encourage creativity and problem-solving, which has contributed to the development of groundbreaking therapies at Aquestive. Barber's leadership style, combined with his extensive industry knowledge, makes him a valuable asset to the company as it continues to pursue its mission of improving the lives of patients through innovative pharmaceutical solutions.